DLPL announced its financial results for the quarter, kicking off FY27 with strong performance.

Revenue reached ₹798 Cr, up 19.1% YoY, while Profit (PAT) surged 27.2% to ₹170 Cr.

This growth was fueled by robust 10.7% sample volume and 8.2% patient volume increases, marking DLPL's highest quarterly revenue growth in four years.

The company's strategy hinges on Scientific Leadership, Patient Experience, and Operational Excellence.

Recent highlights include launching 4 'First in India' tests and expanding its rural outreach program across 7 states, serving over 1,10,000 patients this quarter.

DLPL is also investing in R&D, digital infrastructure, and AI-powered solutions.

Management is confident in sustaining profitable growth, seeing continued structural growth in the Indian diagnostics industry and leveraging a strong cash position for strategic opportunities.